Microcap Ledger

Tickers · $TMCI

Treace Medical Concepts, Inc. $TMCI

By Microcap Ledger desk · CIK 0001630627

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Global Select Market
Sector
Surgical & Medical Instruments & Apparatus
Headquarters
Ponte Vedra, FL
Fiscal year end
December 31
Shares outstanding
65,034,552 [10-Q 2026-08-07]
as of 2026-07-31

Sources: [10-K 2026-02-27]

What the company doesAI summary of filing

Treace Medical Concepts is a revenue-generating medical technology company that develops and sells surgical systems for correcting bunions and related midfoot deformities. The company sells its products primarily through a direct employee sales force and independent sales agencies to hospitals, ambulatory surgery centers, and surgeons in the United States. Its core product, the Lapiplasty 3D Bunion Correction System, is a combination of reusable surgical instruments and single-use sterile implants designed to correct bunion deformities in three dimensions. The company also offers complementary products including minimally invasive bunion correction systems, midfoot correction systems, great toe fusion implants, and patient-specific instrumentation, and generates revenue from sales of these products to healthcare facilities and surgeons. [10-K 2026-02-27]

Segments: Lapiplasty 3D Bunion Correction System, Adductoplasty Midfoot Correction System, Nanoplasty and Percuplasty Minimally Invasive Bunion Correction Systems, SpeedPlate Rapid Compression Implant Platform

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$92.57M−$33.83M $2.54M$12.61M[10-Q 2026-08-07]
FY ended Dec 2025$212.69M−$59.00M −$15.97M$10.71M[10-K 2026-02-27]
FY ended Dec 2024$209.36M−$55.74M −$37.17M$11.35M[10-K 2026-02-27]

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-10-3162,297,078[10-Q 2024-11-05]
2025-02-1962,618,725[10-K 2025-02-27]
2025-04-3062,904,952[10-Q 2025-05-08]
2025-07-3163,173,126[10-Q 2025-08-07]
2025-10-3163,718,073[10-Q 2025-11-06]
2026-02-2064,590,503[10-K 2026-02-27]
2026-04-3064,872,976[10-Q 2026-05-08]
2026-07-3165,034,552[10-Q 2026-08-07]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-09-30Elder Scot Michaelother25,457—[4 2026-10-02]
2026-08-24Treace John T.buy11,000$4.34[4 2026-08-24]
2026-08-21Treace John T.buy5,000$4.35[4 2026-08-24]
2026-08-20Treace John T.buy39,944$4.44[4 2026-08-24]
2026-08-09Scanlan Sean F.other9,814—[4 2026-08-12]
2026-08-09Hair Markother37,102—[4 2026-08-12]
2026-08-09Elder Scot Michaelother16,253—[4 2026-08-12]
2026-06-11Treace John T.buy22,887$4.04[4 2026-06-11]
2026-06-10Treace John T.buy29,430$4.02[4 2026-06-11]
2026-06-01Treace John T.buy50,000$3.56[4 2026-06-01]
2026-05-28Treace John T.buy61,202$3.02[4 2026-05-28]
2026-05-27Treace John T.buy49,810$2.87[4 2026-05-28]

Catalysts and calendar

Facts as of . Small caps move fast; check the latest filings.